Walsky Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.48M Sell
5,400
-235
-4% -$240K 6.01% 1
2026
Q1
$5.18M Buy
5,635
+345
+7% +$350K 5.29% 2
2025
Q4
$5.69M Buy
+5,290
New +$5.06M 5.79% 3

Other funds holding LLY

Walsky Investment Management's LLY Position: Q2 2026 in Review

Walsky Investment Management reduced its Eli Lilly (LLY) stake by 4.2% in Q2 2026, selling an estimated $240K and leaving 5,400 shares worth $6.48M. The position accounts for 6.01% of the portfolio, ranked #1.

Walsky Investment Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Walsky Investment Management held 5,400 shares of Eli Lilly worth $6.48M as of Q2 2026.
  • Walsky Investment Management sold 235 Eli Lilly shares in Q2 2026, an estimated $240K.
  • Eli Lilly made up 6.01% of Walsky Investment Management's portfolio in Q2 2026, its #1 holding.
  • Walsky Investment Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Walsky Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.